Skip to main content
Equibles

MOORE CAPITAL MANAGEMENT, LP

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1448574 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,458,916
+$1,953,225 QoQ
Shares Held
189,946
+79.3% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#45
of 183 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MOORE CAPITAL MANAGEMENT, LP holds $125,911,351 across 33 Biotechnology names. CGEM ranks #16 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 81,700 $15,300,776
2 GMAB
Genmab A/S
 420,487 $11,550,777
3 TECH
BIO-TECHNE Corp
 125,626 $8,875,476
4 IMCR
Immunocore Holdings plc
 274,663 $8,720,550
5 RLAY
Relay Therapeutics, Inc.
 414,005 $7,746,033
6 DYN
Dyne Therapeutics, Inc.
 305,794 $6,791,684
7 PTCT
Ptc Therapeutics, Inc.
 75,588 $6,165,713
8 SLDB
Solid Biosciences Inc.
 603,472 $6,028,685

All Filings in CGEM

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,458,916 189,946
2026-03-31 $1,505,691 105,960